More frequent in-person social interaction is linked with a significantly lower risk of symptoms of major depression and posttraumatic stress disorder (PTSD) in US military veterans, according to a study published online.
Is there benefit in treating a patient with a VMAT2 inhibitor if they have already had severe tardive dyskinesia for several years? Find out here.
Using brain imaging, researchers have identified three distinct neurophysiological subtypes of depression—one of which does not respond to treatment with selective serotonin-reuptake inhibitors.
Use the links here to see all of our coverage of sessions, speakers, and posters at Psych Congress 2018.
Patients with major depressive disorder (MDD) treated with the anticonvulsant ezogabine demonstrated a significant drop in depressive symptoms and an increase in resilience in a small trial described online in Molecular Psychiatry.
Cognitive behavioral humanistic and interpersonal training (CATCH-IT) may be better than health education as a primary care intervention to reduce risk in adolescents with subsyndromal depression, researchers say.
BLOG: On January 18, 2018, in Sacramento California, new mother Jessica Porten went to see a women’s health nurse practitioner. She was 4 months postpartum and had not been seen by her obstetric provider since giving birth.
BLOG: Recent qualitative studies on subjects treated with psilocybin may begin to help us understand the subjective experience caused by the drug that may lead to its antidepressant effects.
BLOG: We psychiatrists read so much about physicians being “difficult patients.” What about when the shoe is on the other foot?
Psych Congress cochair Charles Raison, MD, recently discussed his research and perspectives in an extensive interview with Rhonda Perciavalle Patrick, PhD, who runs the FoundMyFitness website.
Saundra Jain, MA, PsyD, LPC, a Psych Congress Steering Commitee member, explains the Patient Health Questionnaire (PHQ-9), the gold standard measurement tool in major depression.
Mary Kay Lobo, PhD, an assistant professor at the University of Maryland School of Medicine, Baltimore, explains research which suggests a specific gene, Slc6a15, may be central to depression.